Dr Andrew Chantry speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about bone disease in multiple myeloma.
He describes the pathophysiology of this disease and the current treatments available to treat this; along with their disadvantages.
Dr Chantry also mentions the psychological effects this disease can cause and states how future efforts should focus on improving these, along with other aspects to improve patient outcomes.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.